Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Bancorp 34, Inc.Bancorp 34 Reports $1.7 Million Net Income for 2024 After CBOA Merger
ModivCare IncModivCare Reports $201.3 Million Net Loss and 1.3% Revenue Growth for 2024
EVgo Inc.EVgo Inc. Reports 60% Revenue Growth to $256.8 Million for 2024
SYNLOGIC, INC.Synlogic Reports $23.36 Million Net Loss for Fiscal Year 2024, Revenue Drops to $8,000
ALX ONCOLOGY HOLDINGS INCALX Oncology Reports $134.85 Million Net Loss for 2024, Highlights Evorpacept Clinical Trials
Elevation Oncology, Inc.Elevation Oncology Reports $44.5 Million Net Loss for 2024, Highlights EO-3021 Clinical Trial Success
Cidara Therapeutics, Inc.Cidara Therapeutics Reports $169.8 Million Net Loss and Decreased Collaboration Revenue in 2024
Foghorn Therapeutics Inc.Foghorn Therapeutics Reports $86.6 Million Net Loss for 2024, Decreased Collaboration Revenue
Contineum Therapeutics, Inc.Contineum Therapeutics Reports $42.26 Million Net Loss for 2024
FIDUS INVESTMENT CorpFidus Investment Corporation Reports 12.3% Increase in Total Investment Income for 2024
IGM Biosciences, Inc.IGM Biosciences Reports $195.8 Million Net Loss for 2024, Focuses on Immunology
TerrAscend Corp.TerrAscend Corp. Reports $72.7 Million Net Loss and $306.7 Million Revenue for 2024
Adicet Bio, Inc.Adicet Bio Reports $117.1 Million Net Loss for 2024, FDA Clears IND Applications for ADI-001 and ADI-270
CytomX Therapeutics, Inc.CytomX Therapeutics Reports $138.1 Million Revenue for 2024, Driven by Collaborations
AMERICAN PUBLIC EDUCATION INCAmerican Public Education Reports 4% Revenue Growth to $624.6 Million for 2024
Black Diamond Therapeutics, Inc.Black Diamond Therapeutics Reports $69.7 Million Net Loss for 2024, Highlights Progress in BDTX-1535 Trials
Comstock Inc.Comstock Inc. Reports $53.4 Million Net Loss Despite Revenue Growth to $3.0 Million in 2024
Paragon 28, Inc.Paragon 28 Reports 18% Revenue Growth to $256.2 Million in 2024
Oruka Therapeutics, Inc.Oruka Therapeutics Reports $83.7 Million Net Loss and Initiates Phase 1 Trials
REPUBLIC BANCORP INC /KY/Republic Bancorp Reports 12% Increase in Net Income to $101.4 Million for 2024
BuzzFeed, Inc.BuzzFeed Reports $189.9M Revenue in 2024, Faces 18% Decline and Net Loss
BrightSpring Health Services, Inc.BrightSpring Health Services Reports 27.6% Revenue Growth to $11.3 Billion in 2024
Phathom Pharmaceuticals, Inc.Phathom Pharmaceuticals Reports $334.3 Million Net Loss for 2024 Amid Commercial Launch of VOQUEZNA
Bridgewater Bancshares IncBridgewater Bancshares Reports 17.9% Decrease in Net Income for 2024
ALERUS FINANCIAL CORPAlerus Financial Corporation Reports 52% Increase in Net Income for 2024